Navigation Links
Sorafenib Shows Promise for Heart-Lung Disease
Date:5/20/2008

Cancer drug interferes with abnormal cell growth seen in pulmonary hypertension

TUESDAY, May 20 (HealthDay News) -- The cancer drug sorafenib (Nexavar) shows promise as a treatment for pulmonary hypertension, according to a University of Chicago Medical Center study.

During the study, nine patients took the drug for 16 weeks at doses lower than those given to cancer patients. The patients also continued to take their standard medications.

Eight of the patients increased their ability to exercise, six showed significant improvements in their right ventricular ejection fraction (the ability of the heart to pump blood to the lungs), and four had a significant decrease in pulmonary artery pressures.

The most common side effects were diarrhea and hair loss.

The findings were expected to be presented May 20 at the American Thoracic Society annual meeting, in Toronto.

"This is not a disease where we are used to seeing people who have been stable on the strongest medications we have suddenly get better. We have drugs that may slow progression of the disease, but nothing that can stop or reverse the process," study author Dr. Mardi Gomberg-Maitland, an assistant professor of medicine, said in a prepared statement.

"To see these improvements in such a short time is quite promising. Although evaluation of this drug is at a very early stage, and this study focused on safety and tolerability, we are genuinely excited about the results," Gomberg-Maitland said.

Sorafenib was originally developed at the University of Chicago as a treatment for kidney cancer. Both cancer and pulmonary hypertension involve abnormal cell growth. In pulmonary hypertension, the abnormal cell growth occurs in blood vessels that lead to the lungs, causing the vessels to thicken and narrow. This means the heart has to work harder to pump blood to the lungs. This extra workload damages the heart.

Sorafenib
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Analysis shows combining sorafenib with carboplatin/paclitaxel adds no benefit in lung cancer
2. Sorafenib Slows Growth of Some Leukemias
3. With age comes a sense of peace and calm, population research center study shows
4. Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
5. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
6. Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
7. Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows
8. Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children
9. Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File
10. New Survey Shows Americans Value Oral Health But Knowledge Gap Remains
11. Research shows HPV testing offers women protection for twice as long as smear testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... from Boston University School of Medicine (BUSM) and ... who received care through BMC,s Violence Intervention Advocacy ... emotional and social needs of violently injured youthswere ... experienced life changing behaviors through connections to caring, ... and hope. These findings are reported in the ...
(Date:7/22/2014)... from the Sloan-Kettering Institute for Cancer Research in New ... Schools of Medicine and Dentistry have completed research which ... how some cells in the brain and nervous system ... published in the prestigious journal Cancer Cell . ... a tumour suppressor called Merlin. , The results ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 BlogHer, ... for women, this year celebrates its tenth anniversary where ... Thousands of attendees, including community leaders from the new ... representing every consumer vertical, will converge in San Jose ... conversation, and a “selfiebration” of social technology. , ...
(Date:7/22/2014)... SWAMP , the first ... has completed an upgrade that significantly improves the ... with a $23.4 million grant from the ... (DHS S&T), the Software Assurance Marketplace (SWAMP) ... to assess the security of their software, but ...
(Date:7/22/2014)... New study findings released today confirm ... patient-centered program is working to improve the coordination of ... the largest to date and includes more than 200,000 ... that focuses on delivering better quality outcomes, a better ... , “Our most recent study results clearly demonstrate the ...
Breaking Medicine News(10 mins):Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Research brings us nearer to understanding how neuro cells turn cancerous 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 2Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 3Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 4Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 5Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 2Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 3
... Global health organization PSI helps contestants spread HIV prevention ... Bahamas, Aug. 21 The Miss Universe contestants continued preparations for ... tossing water-filled condoms to test their strength and playing "Wild Fire ... The games are part of an HIV peer education workshop designed ...
... ... Mesothelioma Patients , ... Newton, MA (PRWEB) August 21, 2009 -- MesoRC.com, an online community and resource center ... diseases, provides an extra source of valuable information with the introduction of Twitter. The ...
... , , LOS ANGELES, Aug. ... the launch of Energy-X, a new lip balm that delivers an effective ... sweeteners. With zero calories, Energy-X provides the energy boost consumers want without ... "Energy-X is applied directly on the lips and is therefore ...
... , , , ... to a Benefit Concert, Dessert and Auction, featuring LA Collaboration, at ... , 1243 Artesia Blvd, Manhattan Beach, CA - (310) 372-4641 ... price of 1 tickets. , , The concert features ...
... treating a recurrent or residual brain aneurysm that was ... a multicenter study led by researchers at the University ... of 311 patients with coiled aneurysms who underwent retreatment ... death or permanent major disability was slightly over one ...
... , FRAMINGHAM, Mass. and SYDNEY, Aug. ... announced that HeartWare has surpassed 50 implants in the United States ... , , The 50th implant in the ... Houston, Texas by O.H. Frazier, MD a distinguished surgeon, scientist, and ...
Cached Medicine News:Health News:Miss Universe Contestants Enter Condom Olympics to Tackle HIV 2Health News:Miss Universe Contestants Enter Condom Olympics to Tackle HIV 3Health News:Mesothelioma Resource Center Enters Twitter World 2Health News:Energy-X Lip Balm Delivers Wake-Up Call to Consumers 2Health News:The Sensory Research Center (SRC) Offers 2 for 1 Tickets for Benefit Concert Supporting Autism, Down's Syndrome, Cerebral Palsy and Other Disabilities. 2Health News:Study finds low risk in treating previously coiled aneurysm 2Health News:Study finds low risk in treating previously coiled aneurysm 3Health News:HeartWare International Surpasses 50 Implants in the US 2Health News:HeartWare International Surpasses 50 Implants in the US 3
(Date:7/22/2014)... 2014 /PRNewswire-iReach/ -- Reproductive Medicine Associates of New ... ), a nationally and internationally-recognized leader in providing exceptional ... is pleased to announce a new collaboration with EMD ... to recognize the sacrifices made by veterans and their ... Program will allow qualifying veterans and the spouses of ...
(Date:7/22/2014)... -- ConvaTec, a privately-held medical products and technologies company, today ... chief financial officer of the company, effective July 22, ... president and chief financial officer of Elan Corporation, a ... was part of a senior team that helped build ... to Perrigo, a pharmaceutical manufacturer, in December 2013. ...
(Date:7/22/2014)... , July 22, 2014 WuXi PharmaTech (Cayman) Inc. ... medical device R&D outsourcing company with operations in ... , today announced that it will release financial results for ... Exchange closes on Wednesday, August 13, 2014 (which will be ... will be available on the investor relations section of the ...
Breaking Medicine Technology:Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ...
... modified battery chargers are ... for GENIE blotters. They ... very specific voltages, giving ... laboratory power supplies. 110 ...
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
Inquire...
Medicine Products: